Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Customers Bancorp, Inc. (CUBI)
|
Add to portfolio |
|
|
|
| Price: |
$67.00
| | Metrics |
| OS: |
31.3
|
M
| |
|
|
| Market cap: |
$2.1
|
B
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$46.55
| |
1.44
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 762.9 | 467.5 | 312.6 | 43.2 | 339.5 | 302.8 | 203.4 |
| Revenue growth | -100.0% | 63.2% | 49.6% | 622.9% | -87.3% | 12.1% | 48.9% | 25.3% |
| Cost of goods sold | 0.0 | 120.3 | 105.4 | 91.4 | 116.7 | 106.7 | 91.0 | 67.4 |
| Gross profit | 0.0 | 642.6 | 362.1 | 221.2 | -73.4 | 232.8 | 211.9 | 136.0 |
| Gross margin | | 84.2% | 77.4% | 70.8% | -169.8% | 68.6% | 70.0% | 66.8% |
| Selling, general and administrative | 0.0 | | | | | | | |
| Sales and marketing | 0.0 | 1.5 | 1.8 | 2.7 | 2.4 | 1.5 | 1.5 | 1.5 |
| Research and development | | 83.5 | 50.7 | 45.1 | 44.5 | 45.9 | 26.8 | 10.6 |
| General and administrative | 0.0 | 26.7 | 13.6 | 10.6 | 20.2 | 28.1 | 20.7 | 11.0 |
| EBIT | 0.0 | 444.8 | 187.2 | 110.9 | -146.2 | 151.0 | 159.3 | 112.7 |
| EBIT margin | | 58.3% | 40.0% | 35.5% | -338.0% | 44.5% | 52.6% | 55.4% |
| Pre-tax income | 228.0 | 441.2 | 189.8 | 107.8 | 91.1 | 123.9 | 124.6 | 88.5 |
| Income taxes | 0.0 | 86.9 | 46.7 | 26.4 | 19.4 | 45.0 | 45.9 | 29.9 |
| Tax rate | 0.0% | 19.7% | 24.6% | 24.5% | 21.3% | 36.4% | 36.8% | 33.8% |
| Net income | 218.4 | 300.1 | 118.5 | 64.9 | 57.2 | 64.4 | 69.2 | 56.1 |
| Net margin | | 39.3% | 25.4% | 20.8% | 132.4% | 19.0% | 22.8% | 27.6% |
| |
| Diluted EPS | $6.51 | $8.91 | $3.74 | $2.05 | $1.78 | $1.97 | $2.31 | $1.96 |
| Shares outstanding (diluted) | 33.5 | 33.7 | 31.7 | 31.6 | 32.2 | 32.6 | 30.0 | 28.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|